"Prevention of Adenoviral Acute Respiratory Disease in Army Recruits: Cost-Effectiveness of a Military Vaccination Policy."

According to the authors' abstract of an article published in American Journal of Preventive Medicine, "Introduction: Since 1971 widespread vaccination has limited the number of adenoviral acute respiratory disease (ARD) outbreaks in [U.S.] Army recruits. Increased vaccine costs have recently threatened the continuation of the vaccination program. Methods: We conducted a cost-effectiveness analysis to assess the consequences of changing the year-round Army adenovirus vaccination program to (1) seasonally targeted vaccine administration (only during the high-risk period) or (2) complete discontinuation of the program from the perspective of total cost to the Army. Costs...

Want to see the full article?

• Purchase this article for only $3.00